Roche Holding AG (SWX:ROG)
322.30
+1.60 (0.50%)
Inactive · Last trade price on Mar 16, 2026
Roche Holding AG Revenue
In the year 2025, Roche Holding AG had annual revenue of 63.36B CHF with 1.54% growth. Roche Holding AG had revenue of 31.51B in the half year ending December 31, 2025, with 5.64% growth.
Revenue
63.36B
Revenue Growth
+1.54%
P/S Ratio
4.06
Revenue / Employee
613.62K
Employees
103,249
Market Cap
257.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 63.36B | 961.00M | 1.54% |
| Dec 31, 2024 | 62.40B | 1.95B | 3.23% |
| Dec 31, 2023 | 60.44B | -5.37B | -8.16% |
| Dec 31, 2022 | 65.81B | -36.00M | -0.05% |
| Dec 31, 2021 | 65.85B | 5.51B | 9.13% |
| Dec 31, 2020 | 60.34B | -3.41B | -5.35% |
| Dec 31, 2019 | 63.75B | 4.25B | 7.15% |
| Dec 31, 2018 | 59.50B | 3.75B | 6.73% |
| Dec 31, 2017 | 55.75B | 3.11B | 5.91% |
| Dec 31, 2016 | 52.64B | 2.23B | 4.43% |
| Dec 31, 2015 | 50.40B | 537.00M | 1.08% |
| Dec 31, 2014 | 49.87B | 1.25B | 2.58% |
| Dec 31, 2013 | 48.61B | 1.17B | 2.46% |
| Dec 31, 2012 | 47.44B | 3.33B | 7.55% |
| Dec 31, 2011 | 44.11B | -5.05B | -10.28% |
| Dec 31, 2010 | 49.17B | -1.98B | -3.88% |
| Dec 31, 2009 | 51.15B | 3.25B | 6.78% |
| Dec 31, 2008 | 47.90B | -472.00M | -0.98% |
| Dec 31, 2007 | 48.38B | 4.94B | 11.38% |
| Dec 31, 2006 | 43.43B | 6.47B | 17.52% |
| Dec 31, 2005 | 36.96B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRoche Holding AG News
- 1 day ago - The Zacks Analyst Blog Roche Holding, AT&T and Amgen - Nasdaq
- 2 days ago - Top Stock Reports for Roche, AT&T & Amgen - Nasdaq
- 2 days ago - Roche Announces Launch Of Cobas MPX-E Assay - Nasdaq
- 2 days ago - Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supply - GlobeNewsWire
- 5 days ago - Vector Institute Extends Collaboration With Roche - GlobeNewsWire
- 8 days ago - Roche launches the cobas eplex respiratory pathogen panel 3, a fast and comprehensive test to help clinicians treat patients with respiratory infections, in CE markets - PRNewsWire
- 9 days ago - Roche inaugurates new research home for the Institute of Human Biology, pioneering human model systems to accelerate drug discovery and development - GlobeNewsWire
- 9 days ago - Roche Halts Development of Drug Candidate for Muscle Diseases, Chugai Says - WSJ